Navigation Links
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
Date:9/18/2009

tional pending litigation with other companies, including an alleged trademark infringement suit. (North American Medical vs. Axiom Worldwide No. 1:06-CV-1678-JTC)

Hako-Med offers a special amnesty period from civil litigations for any physician who wants to upgrade from an infringing device to Hako-Med Horizontal Therapy devices by the end of October 2009. (www.hakomed.com)

Hako-Med's policy is to vigorously defend its intellectual property portfolio. Hako-Med is the only manufacturer and supplier of devices with the patented Horizontal Therapy. Horizontal Therapy has been known through many clinical trials to outperform existing treatment methods in the treatment of pain from Osteoarthritis by having immediate as well as longer lasting therapeutic effects without any negative side effects.

For interviews please contact. Kai Hansjurgens president of Hako-Med USA at 1-888-913-7900 www.hakomed.com.

###

Read the full story at http://www.prweb.com/releases/Horizontal_Therapy/Patent_Infringement/prweb2905684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. AXIOM Selects Foresight Corp. for Integration Partnership
2. Axiom Named to Healthcare Informatics Top 100 List
3. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
4. Global Decompression Announces C.O.D. Available on All Used Axiom DRX 9000 Spinal Decompression Systems
5. WorldatWork Publishes Axiom Consulting Partners' Article on ‘Planning for the New Normal', an Alternative Approach to Compensation Planning
6. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
7. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
8. Global Med Technologies(R) Extends Its Worldwide Outreach
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
11. New USAID grant helps Georgetown meet unmet family planning needs worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
(Date:12/26/2014)... The Biofeedback Federation of Europe annual meeting is ... Italy and is hosted by the Salesian Pontifical University. ... wide variety of topics such as ADHD, anxiety, headaches ... athletes. The scientific program will feature the latest in ... clients to see what is going on in their ...
(Date:12/26/2014)... WA (PRWEB) December 26, 2014 “Many ... deal with personal injury claim issues and phone calls ... recently released an article featuring their free eBook ... exceptionally helpful eBook on pedestrian and bicycle auto accident ... attorney is fully capable of professionally handling their case ...
(Date:12/26/2014)... December 26, 2014 Pentec Health, Inc. ... the state of Pennsylvania for 2014. The awards program, ... programs of its kind in the country. The program ... Pennsylvania Department of Community and Economic Development, the Pennsylvania ... and the Central Penn Business Journal. , ...
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3
... Toronto Stock Exchange Symbol: CYT, MONTREAL, Nov. ... global leader in cryotherapy products to treat cardiac,arrhythmias, ... of,CryoCath, will present at both the Piper Jaffray ... on Healthcare Conference. The Piper Jaffray,Conference presentation will ...
... Trigger Milestone Payments Totaling $1 Million to ... ... PCOP ), an innovator in the discovery and development of ... compounds for advancement in its alliance with GlaxoSmithKline (NYSE:,GSK), through its ...
... movie is a,psychological thriller that tells the story of a ... but paralyzed,during heart surgery., It has been 30 years ... ,Coma, is the gripping story of patients,who check into a ... "Five years after the book and movie, I still ...
... of Hematology ... (ASH) Annual Meeting, SEATTLE, Nov. ... announced it intends to utilize the,results of the phase III first-line ... submission to the United States Food,and Drug Administration (FDA) for potential ...
... Today at 10:30 CET, AMSTERDAM, November 27 ... the field of human gene therapy,today announced it ... the,development of AAV-mediated insulin-like growth factor I (IGF-I) ... CET today, the company,s,management will hold a conference ...
... is a close relationship between infection outbreaks on teeth and ... of hair loss which has an unknown origin. Alopecia areata ... on the body. The disease occurs in males and females ... out 1000 people. , Research by professors Jos Antonio Gil ...
Cached Medicine News:Health News:CryoCath to present at Piper Jaffray and BMO Healthcare conferences 2Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 2Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 3Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 4Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 5Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 3Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 2Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 3Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 4Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 5Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 6Health News:Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008 2Health News:Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008 3Health News:Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008 4Health News:Infection outbreaks on teeth can cause 'alopecia areata' or localized hair loss 2
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... decision support to healthcare providers for behavioral health ... has secured $30 million in equity financing from ... C. Drosos , President and Chief Executive Officer. ... adoption and development of Assurex Health,s GeneSight ...
(Date:12/24/2014)... , Dec. 23, 2014  Endo Pharmaceuticals Inc., ... ENDP ) (TSX: ENL), and BioDelivery Sciences International, Inc. ... have submitted a New Drug Application (NDA) for Buprenorphine ... Administration (FDA).  Buprenorphine HCl Buccal Film is under development ... daily, around-the-clock, long-term opioid treatment and for which alternative ...
(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ... Self-monitoring Blood Glucose Market" report to their offering. ... This market insight focuses on the developments in the ... States . Reimbursement analysis and the effects of ... more than 73 SMBG meters have been performed, based ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2
... TAXUS(R) Stent shows no additional very late stent ... 4 ,Boston Scientific Corporation (NYSE: BSX ) ... II clinical trial, demonstrating continued,long-term safety and efficacy ... the TAXUS stent showed no additional stent,thrombosis between ...
... investigators at the,European Society of Cardiology Congress 2007 (ESC ... continued to,provide clinical benefits compared to a bare metal ... follow-up with no differences in safety. At five-year ... the,study continued to be significantly less likely than the ...
Cached Medicine Technology:Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 2Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 3Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 4Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 2Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 3Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 4Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 5
... Releasing the power of clinical information. ... newest generation of clinical connectivity solutions that ... provide effective, high-quality patient care. You will ... be able to share it with your ...
... tool for Clinical Professionals and Researchers., ,S/5 ... easy and efficient way to collect data from ... to days at selectable time intervals. With S/5 ... from the monitor via an interface cable or ...
... Flexible monitoring for intermediate care., ,The ... GE Healthcare Datex-Ohmeda S/5 product line., ,The ... you the power to grow. The new Patient ... hemodynamic measurements up to 12-lead ECG, NIBP, ...
... ,The Datex-Ohmeda S/5 Light Monitor is a ... and critical care areas, in emergency or medium-care ... part of the Datex-Ohmeda S/5 family, the S/5 ... and design shared by all S/5 monitoring products ...
Medicine Products: